By Rishika Sadam HYDERABAD, India, Dec 3 (Reuters) - Danish drugmaker Novo Nordisk will launch its blockbuster diabetes drug ...

The popularity of GLP-1 weight loss drugs might be expanding to our pets. New research is underway for something being called ...

The Morning Addition team talk about their Spotify Wrapped lists (why is Annie's listening age so old?) and the new trials to ...

Danish drugmaker Novo Nordisk will launch its blockbuster diabetes drug Ozempic in India this month, three sources familiar ...

CLEVELAND, Ohio — One in eight adults in the United States are now using Ozempic, Wegovy or similar GLP-1 drugs, according to ...

The World Health Organization conditionally recommended GLP-1 drugs for obesity. A physician breaks down what you need to ...

Novo Nordisk A/S left open the door for additional work on its pill version of Ozempic for Alzheimer’s disease after a pair ...

Low-dose semaglutide (Ozempic, Wegovy) improved glycemic control and weight outcomes in a randomized trial of adults whose ...

As people’s bodies change because of GLP-1s, so does their spending across industries including fashion, restaurants, gyms ...

Beyond weight loss, berberine also has a few other potential benefits to be aware of.

The next-generation “GLP-1 plus” drugs will be tailored to the health needs of individual patients.

Novo, which in September said it secured Indian regulatory approval to import and sell Ozempic, on Thursday said it hoped to ...